Marfan Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Marfan Syndrome Clinical Trials Overview
The report provides an overview of the Marfan Syndrome clinical trial scenario and top-line data relating to the clinical trials. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7), phase, trial status, end points status, and sponsor type.
Key Regions | · Europe
· North America · Asia-Pacific |
Key Countries | · The US
· The UK · Canada · Italy · France |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Cambridge Consortium Ltd (Inactive)
· Novartis AG · Mesa Science Associates Inc · Merck & Co. Inc · A. Menarini Industrie Farmaceutiche Riunite Srl |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Marfan Syndrome Clinical Trials Segmentation by Regions and Countries
The key regions considered for Marfan Syndrome clinical trials analysis are Asia-Pacific, Europe, and North America. Europe led the Marfan Syndrome clinical trials landscape as of November 2023.
In the country-wise analysis, the UK has the highest number of Marfan Syndrome clinical trials, as of November 2023. Belgium has the highest average patient enrollment of Marfan Syndrome clinical trials, as of November 2023.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United Kingdom has the highest proportion of Marfan Syndrome to Genetic Disorders clinical trials as of November 2023.
Marfan Syndrome Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Marfan Syndrome Clinical Trials
Marfan Syndrome Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Marfan Syndrome clinical trials are company, institution, and the government. As of November 2023, the institution sponsor type dominated the Marfan Syndrome clinical trials share, followed by the company sponsor type.
Marfan Syndrome Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Sponsor Type Insights into Marfan Syndrome Clinical Trials
Marfan Syndrome Clinical Trials - Competitive Landscape
Some of the leading sponsors for Marfan Syndrome clinical trials are:
- Cambridge Consortium Ltd (Inactive)
- Novartis AG
- Mesa Science Associates Inc
- Merck & Co. Inc
- Menarini Industrie Farmaceutiche Riunite Srl
In 2023, F. Hoffmann-La Roche Ltd conducted the highest number of Cambridge Consortium Ltd (Inactive). It is followed by Novartis AG.
Marfan Syndrome Clinical Trials Analysis by Sponsors, 2023 (%)
Buy the Full Report to Know More About the Leading Players in Marfan Syndrome Clinical Trials
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by Region, Country (G7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews the top companies involved and enlists all trials (Trial title, Phase, and Status) about the company
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with the reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies about investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
A. Menarini Industrie Farmaceutiche Riunite Srl
Merck & Co Inc
Mesa Science Associates Inc
Novartis AG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Marfan Syndrome clinical trials?
Europe accounted for the highest number of Marfan Syndrome clinical trials as of November 2023.
-
Which country conducted the highest number of Marfan Syndrome clinical trials?
The UK conducted the highest number of Marfan Syndrome clinical trials as of November 2023.
-
Which sponsor type was the most prominent in the Marfan Syndrome clinical trials?
The institution sponsor type was most prominent for Marfan Syndrome clinical trials.
-
Who are the leading sponsors of Marfan Syndrome clinical trials?
Some of the leading sponsors of Marfan Syndrome clinical trials are Cambridge Consortium Ltd (Inactive), Novartis AG, Mesa Science Associates Inc, Merck & Co. Inc, and A. Menarini Industrie Farmaceutiche Riunite Srl.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.